Clinical trials in Israel
10,751 studies list at least one site in Israel. 1,233 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Israel recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Sheba Medical Center (576) · Hadassah Medical Organization (573) · Tel-Aviv Sourasky Medical Center (410) · Rambam Health Care Campus (358) · Rabin Medical Center (343) · Meir Medical Center (325) · Hillel Yaffe Medical Center (255) · Novartis Pharmaceuticals (252)
What changed recently
From the registry's own updates since Oct 12, 2026.
Started recruiting10
- IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel SyndromeNov 10, 2026NCT07707635
- A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)Nov 4, 2026NCT07709000
- A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaNov 3, 2026NCT07746687
- A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerNov 3, 2026NCT07906717
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
Show 5 moreShow fewer
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Oct 26, 2026NCT07476729
- A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical PracticeOct 19, 2026NCT07344779
- A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)Oct 16, 2026NCT07743164
- Assessing the Potential Role of the Gut Microbiome in Modulating Physical Abilities in HumansOct 13, 2026NCT05024188
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)Oct 13, 2026NCT07817875
First site in Israel18
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisNov 10, 2026NCT06429176
- IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel SyndromeNov 10, 2026NCT07707635
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionNov 9, 2026NCT07546500
- Effects of a Single Oral Dose of Sweet Protein Sweelin® on Blood Glucose and Insulin Levels in Healthy AdultsNov 4, 2026NCT06520293
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsNov 3, 2026NCT06663332
Show 13 moreShow fewer
- A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaNov 3, 2026NCT07746687
- A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerNov 3, 2026NCT07906717
- A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeNov 2, 2026NCT07503444
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0Oct 28, 2026NCT06823115
- Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaOct 28, 2026NCT07249905
- A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant SettingOct 27, 2026NCT07022483
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationOct 19, 2026NCT07064759
- A Study of ZL-1310 in Subjects With Small Cell Lung CancerOct 16, 2026NCT06179069
- Whey Protein Milk-Derived ExosomesOct 16, 2026NCT06755021
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 16, 2026NCT07185009
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisOct 15, 2026NCT07697456
- Assessing the Potential Role of the Gut Microbiome in Modulating Physical Abilities in HumansOct 13, 2026NCT05024188
- A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaOct 13, 2026NCT06980480
Results posted20
- Pilot Study of Nivolumab in Pediatric Patients With Hypermutant CancersNov 5, 2026NCT02992964
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantNov 4, 2026NCT04543591
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsNov 4, 2026NCT04578834
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)Nov 4, 2026NCT04968184
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
Show 15 moreShow fewer
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)Nov 2, 2026NCT04502030
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)Oct 30, 2026NCT04488133
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Oct 30, 2026NCT04861259
- KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)Oct 29, 2026NCT04165083
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)Oct 22, 2026NCT03036488
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsOct 22, 2026NCT04420884
- A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)Oct 20, 2026NCT04630028
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Oct 15, 2026NCT04701983
- Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisOct 15, 2026NCT05255991
Stopped9
- High-Dose Ambroxol in GBA1-Related ParkinsonTerminatedNov 9, 2026NCT06193421
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureTerminatedNov 5, 2026NCT05603104
- Long-term Extension of GTX-102 in Angelman SyndromeTerminatedNov 3, 2026NCT06415344
- A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)TerminatedNov 3, 2026NCT07157254
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaWithdrawnOct 30, 2026NCT07084831
Show 4 moreShow fewer
- A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube CancerTerminatedOct 28, 2026NCT05613088
- Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes MellitusTerminatedOct 26, 2026NCT05631431
- A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)TerminatedOct 21, 2026NCT05382325
- A Study to Assess the Safety and Efficacy of UNO - Ultra High Concentration Nitric Oxide Injection in Combination With PD-1 Inhibitors Into Unresectable Solid Primary or Metastatic TumorsTerminatedOct 13, 2026NCT05351502
Newly registered29
- Phase 2 Study of pH Gastrilex™ (Enteric-Coated Amorphous Calcium Carbonate Capsules) in Moderate-to-Severe Crohn's DiseaseNov 10, 2026NCT07928700
- Concomitant Fibromyalgia and Psychiatric DisordersNov 6, 2026NCT07920913
- Split-Belt Treadmill Training to Improve Walking After Hip FractureNov 6, 2026NCT07923149
- Real-world Study of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis and Progressive Pulmonary FibrosisNov 5, 2026NCT07919015
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
Show 24 moreShow fewer
- Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac PatientsNov 3, 2026NCT07913152
- Rigid Hymenal Ring as a Cause for Insertional DyspareuniaNov 3, 2026NCT07913386
- Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among AdolescentsNov 3, 2026NCT07913425
- Time Course of Clozapine-associated Agranulocytosis Over 19 YearsNov 3, 2026NCT07913529
- Multi-biomarkers in DEENov 2, 2026NCT07909382
- Pre-Examination Reflexology for Anxiety and Pain During Pelvic ExaminationNov 2, 2026NCT07910136
- Effects of Brief Heart Rate Variability Biofeedback on Physiological and Emotional ResponsesNov 2, 2026NCT07911215
- A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerOct 30, 2026NCT07906717
- Perception of Action Opportunities for Obstacle Crossing in Parkinson's DiseaseOct 30, 2026NCT07907770
- Evaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different DiseasesOct 28, 2026NCT07900412
- 1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder TumorsOct 27, 2026NCT07898033
- Safety, Tolerability, and Efficacy of Oral KM-023 in Adult Patients With Pachyonychia Congenita (pEDD-PC)Oct 26, 2026NCT07893483
- Organ Culture for Endocrine Resistant Next Line: A Treatment Selection Study in Metastatic Breast CancerOct 26, 2026NCT07895160
- Methadone Administration in Critically Ill Patients in the Intensive Care Unit and Risk of Prolonged QTc and Cardiac ArrythmiaOct 23, 2026NCT07892677
- Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post- Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Vaginal Delivery With Epidural Analgesia: A Double- Blind Randomized Controlled TrialOct 23, 2026NCT07893119
- Deep TMS for PTSD With Suicidal IdeationOct 19, 2026NCT07880340
- Inactivated UPEC-FimON for Non Muscle Invasive Bladder Cancer After BCG or Intravesical Chemotherapy FailureOct 19, 2026NCT07881666
- Foot Reflexology for Anxiety in Women Hospitalized With High-Risk PregnancyOct 16, 2026NCT07878637
- The Impact of Hyperbaric Oxygen Therapy on Vocal Performance in Professional SingersOct 16, 2026NCT07879040
- Hazardous Substances InjuriesOct 16, 2026NCT07879261
- Predictors of Successful Office Operative Hysteroscopy Using a Mini-ResectoscopeOct 15, 2026NCT07875985
- Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain AmyloidosisOct 14, 2026NCT07874334
- Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior UveitisOct 13, 2026NCT07869953
- ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy AgingOct 13, 2026NCT07871799
Studies
Recruiting first, then most recently updated. Showing 50 of 10,751 — search for more.
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisRecruitingNCT06429176Phase 2
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDRecruitingNCT06659549Phase 2
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT05650632Phase 1
- A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).RecruitingNCT06843447Phase 1/2
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
- A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)RecruitingNCT06951711Phase 3
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)RecruitingNCT06717347Phase 3
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingNCT06824467Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)RecruitingNCT06818643Phase 1/2
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson DiseaseRecruitingNCT07227896
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 3
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruitingNCT07555938Phase 3
- A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)RecruitingNCT07709000Phase 2
- IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel SyndromeRecruitingNCT07707635Not applicable
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)RecruitingNCT07222488Phase 1/2
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)RecruitingNCT07190248Phase 3
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)RecruitingNCT07634471Phase 2/3
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]RecruitingNCT07099898Phase 3
- A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)RecruitingNCT07489495Phase 3
- A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)RecruitingNCT07519772Phase 1/2
- A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)RecruitingNCT07570173Phase 2/3
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)RecruitingNCT07276724Phase 3
- Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT07284459Phase 2
- A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)RecruitingNCT07419295Phase 3
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)RecruitingNCT07318558Phase 3
- A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)RecruitingNCT07743164Phase 3
- Evaluation of A Clinical Diagnostic Test for CRDSRecruitingNCT06188689Not applicable
- A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)RecruitingNCT06623422Phase 3
- Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).RecruitingNCT06133972Phase 3
- Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative RadiotherapyRecruitingNCT05560659Phase 2
- VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruitingNCT06237452Phase 3
- A Platform Trial for Gram Negative Bloodstream InfectionsRecruitingNCT06537609Not applicable
- Long-Term Outcomes of Teplizumab in Routine Clinical CareRecruitingNCT07360080
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruitingNCT07091630Phase 3
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionRecruitingNCT07546500Phase 3
- A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's DiseaseRecruitingNCT07737743Phase 2
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)RecruitingNCT07227597Phase 1/2
- A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)RecruitingNCT07513376Phase 3
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruitingNCT07776509Phase 3
- A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruitingNCT06215716Phase 3